Document:

EX-10.1

 Exhibit 10.1 

RETIREMENT AND CONSULTING AGREEMENT 

The parties to this Retirement and Consulting Agreement (the “Agreement”) are Union Electric Steel Corporation (the
“Company”) and Robert G. Carothers (the “Executive”). This Agreement is entered into and will become effective as of May 1, 2016 (the “Effective Date”). 

The Executive has announced his decision to retire from the Company as Chairman and Chief Executive Officer and Chairman, President and Chief
Executive Officer of the Forged and Cast Engineered Products Group effective April 30, 2016 (the “Retirement Date”). Following the Retirement Date, the Company wishes to retain the Executive for the purpose of providing, and the
Executive has agreed to provide, certain consulting services. This Agreement is intended to set forth the terms applicable to the Executive’s retirement from the Company and the consulting arrangement following the Retirement Date. 

NOW, THEREFORE, the parties, intending to be legally bound, agree as follows: 

1. Resignation and Retirement. Effective on the Retirement Date, the Executive will resign from all positions with the Company and any subsidiaries of
the Company then held by him, except for his position as a director of each of Gongchang Roll Co., Ltd and Union Electric Steel MG Roll Co., Ltd (a/k/a “Masteel Gongchang Roll Company”)) and the Executive’s employment with the Company
will terminate due to his retirement. 
 2. Consulting Services. 

(a) General. Beginning on May 1, 2016 and ending on May 31, 2017 (such period, subject to the extension and early termination
provisions of Section 2(d) below, the “Consulting Period”), the Executive agrees to cooperate with the Company in the transition of management of the Company following Executive’s retirement and to provide such consulting
services to the Company (the “Consulting Services”) as may be requested by the President of the Company or the Chief Executive Officer of Ampco-Pittsburgh Corporation and be agreed to by the Executive, which agreement may not be
unreasonably withheld by Executive. The Executive agrees to provide up to five (5) days of Consulting Services to the Company per month during the Consulting Period with the exception of the entire months of February and March, 2017. 

(b) Independent Contractor Status and Performance of Consulting Services. Nothing contained in this Agreement will be deemed to create
an employment relationship between the Company and the Executive during the Consulting Period. In providing the Consulting Services, the Executive agrees and acknowledges that he is an independent contractor and will not have authority to bind the
Company with respect to any matter. In rendering Consulting Services under this Agreement, the Executive will be free to arrange his own time, pursuits and work schedule and to determine the specific manner in which such services will be performed,
without being required to observe any routine or requirement as to working hours. 
 (c) Non-exclusivity; Non-Competition. The
Company agrees and acknowledges that Executive may offer consulting services to other persons (but not to any competitor of the Company or Ampco-Pittsburgh Corporation) during the Consulting Period, subject to the confidentiality and proprietary
rights provisions of this Agreement. Notwithstanding the foregoing, the Executive agrees not to engage in, or carry on, directly or through any 

 
representative or affiliate, either for itself or as a member of a partnership or as a stockholder, investor, officer or director of a corporation or as an employee, agent, associate, adviser or
consultant to or of any person, partnership, corporation or other entity, any business that is competitive with a business that the Company or any other subsidiary of Ampco-Pittsburgh Corporation is engaged in as of the Retirement
Date; provided that nothing in this provision shall restrict the Executive from the Executive’s passive ownership of up to 2% of a publicly traded stock in one or more public companies engaged in a competing business. For the
avoidance of doubt, any breach of this clause shall constitute a material breach of this Agreement. 
 (d) Extension or Early Termination
of Consulting Period. This Agreement and the applicable Consulting Period may be extended beyond the term described in Section 2(a) by mutual agreement of the parties. Notwithstanding any provisions to the contrary in this Agreement, this
Agreement may be terminated prior to May 31, 2017 and the Consulting Period will be deemed to have expired upon any of the following: 

(i) the mutual written agreement of the parties providing for such termination; 

(ii) upon written notice of such termination from either party to the other party, provided such notice is provided to the
other party at least thirty (30) days prior to the effective date of the termination; 
 (iii) immediately upon notice
by the Company to the Executive of the Executive’s breach of any covenant set forth in Sections 2(c), 8, and 9 of this Agreement; 

(iv) upon the death of the Executive; and 

(v) in the event of a material breach by the Executive of this Agreement, which remains uncured within 15 days after the
Company provides written notice to the Executive of such breach. 
 3. Payments and Benefits. 

(a) In Connection With Executive’s Retirement. Upon the Executive’s retirement and termination from employment with the
Company, the Executive will be entitled to payment of all accrued, but unpaid, salary, bonus, vacation or paid time-off and business expenses (to the extent properly accounted for) as of the Retirement Date. In addition, the Executive will be
entitled to all accrued and vested retirement benefits under any qualified or nonqualified plans or arrangements sponsored by the Company in accordance with the terms and provisions of such plans or arrangements; provided, the Executive will not
accrue additional service or benefits under such plans during the Consulting Period. Following the expiration of the Consulting Period, the Executive will be covered by the Company’s retiree life insurance coverage in accordance with the terms
of that arrangement. 
 (b) Bonus for 2016. The Executive will be eligible to receive a pro rata portion (4/12) of any
short-term incentive award awarded under the Company’s short-term incentive program for the 2016 fiscal year, based on achievement of the applicable performance goals for the year. The pro rata award, if any, will be paid at the same time when
short-term incentive awards are paid to other eligible employees of the Company. Except as described in this Section 3(b), the Executive will not be entitled to any bonus or incentive compensation during the Consulting Period. 

  
 - 2 - 

 (c) Automobile. The Executive will have the right to purchase the leased Company car, , at
a price equal to the lesser of its then book value or market value on the date the right is accepted. This right will expire on May 31, 2017 and the Executive may continue to use the vehicle until that time. 

(d) In Connection With Consulting Services. In consideration for the Consulting Services to be provided by the Executive under this
Agreement, the Company agrees to pay or provide the Executive the following compensation or benefits during the Consulting Period: 

(i) The amount of Two Hundred Fifty ($250) dollars per hour worked (collectively, the “Payments”) including travel
hours (time in air or on road to get to destination) associated with out of town assignments; 
 (ii) The Company will
arrange to provide the Executive at the Company’s expense with the same travel accident insurance coverage applicable to Executive immediately prior to the Retirement Date; 

(iii) The Company will provide or reimburse the Executive for the cost of home computer, printer, cellular phone, iPad and
secretarial support services; 
 (iv) The Company will reimburse the Executive for all out-of-pocket expenses reasonably and
necessarily incurred in the performance of the Consulting Services in accordance with the travel and business expense reimbursement policies of the Company in effect from time to time. In the event of travel required outside of North America,
Business Class Airline Service is allowed; 
 (v) All stock option, restricted stock units (“RSUs”) or performance
share unit (“PSUs”) awards granted to the Executive and outstanding on the Retirement Date will, notwithstanding the terms of such awards, continue to vest during the Consulting Period as if the Executive had continued to be employed with
the Company through the end of the Consulting Period, and to the extent the award is not vested as of the end of the Consulting Period, the terms regarding vesting and forfeiture of the award under the applicable award agreement will be applied
at that time; in addition, to the extent vested, outstanding options will be exercisable by the Executive during the Consulting Period, and any post-employment exercise provisions will be applied at the end of the Consulting Period, but in no event
may such options be exercised beyond the applicable expiration date or term of the option; and 
 (vi) The Executive will
continue to be eligible to receive RSUs and PSUs or other equity awards during the Consulting Period, but such grants, if any, will be in the sole discretion of the Compensation Committee of the Board. 

(e) Compliance with Section 409A. The parties to this Agreement intend that the Agreement complies with Section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”), or an applicable exemption thereto, including, where applicable, the short-term deferral 

  
 - 3 - 

 
exception, and this Agreement will be interpreted in a manner consistent with that intention. For purposes of Section 409A of the Code, each payment made under this Agreement will be
designated as a “separate payment” within the meaning of the Section 409A of the Code. Notwithstanding anything to the contrary herein, except to the extent any expense, reimbursement or in-kind benefit provided pursuant to this
Agreement does not constitute a “deferral of compensation” within the meaning of Section 409A of the Code: (a) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Consultant during any calendar
year will not affect the amount of expenses eligible for reimbursement or in-kind benefits provided to the Consultant in any other calendar year, (b) the reimbursements for expenses for which the Consultant is entitled to be reimbursed will be
made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred, and (c) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any
other benefit. 
 4. Reasonable Efforts. The Executive will use reasonable efforts to perform the Consulting Services in a prompt, competent and
diligent manner consistent with the Company’s standards. 
 5. Proprietary Rights. The Executive agrees that all information, discoveries,
inventions, improvements, strategies or overall business plan concepts arising from or in connection with the Consulting Services under this Agreement will be the sole property of the Company and the Executive will cooperate with the Company’s
reasonable requests for the transfer of any such rights or interests from the Executive to the Company. 
 6. Taxes. The Executive acknowledges that
he will be solely responsible for and the Company will have no liability with respect to any taxes (including penalties and interest) imposed by any Federal, state or local government on the Payments or any other benefits payable to or provided on
behalf of the Executive for the Consulting Services under Section 3(d) of this Agreement. 
 7. Insurance and Indemnification. The Company
agrees to insure and to indemnify and hold harmless the Executive from any and all claims and causes of action arising out of the performance of the Consulting Services to the same extent that it insures and indemnifies its officers and directors.

 8. Non-Disparagement. 
  

	 	(a)	At all times hereafter, Executive will not disparage or criticize, orally or in writing, the business, products, policies, decisions, directors, officers or employees of the Company or any of its operating divisions,
subsidiaries or affiliates to any person. 

  

	 	(b)	 At all times hereafter, the Company and its officers, directors, employees and agents will not disparage or
criticize, orally or in writing, Executive; provided that the foregoing shall not be construed to prevent either party from testifying truthfully before any court, tribunal or other legal proceeding. The Executive understands that the
Company’s non-disparagement obligations under this section extend only to the Company’s and Ampco-Pittsburgh Corporation’s Board of 

  
 - 4 - 

	 	
Directors and officers that report directly to the CEO of Ampco-Pittsburgh Corporation and only for so long as each individual is an employee or director of the Company. 

9. Confidentiality; Non-Solicitation; Return of Company Property. 

(a) Confidentiality. During the course of providing the Consulting Services, the Executive may obtain information that is considered to be
confidential and proprietary information of the Company. The Executive agrees to maintain as confidential all confidential information received or obtained as a result of the services provided. At no time shall such confidential information be
disclosed to any third party without the prior written consent of the Company. Notwithstanding the foregoing, the Executive will have no obligation under this Agreement to keep confidential any confidential information to the extent that a
disclosure of it is required by law or is consented to by the Company. 
 (b) Non-Solicitation. During the Consulting Period, the Executive
will not, directly or indirectly recruit, solicit or induce, or attempt to induce, any employee, consultant or vendor of the Company or its affiliates to terminate employment or any other relationship with the Company or its applicable affiliate.

 (c) The Executive agrees, upon one or more requests from the Company, to deliver to it all documents and materials, of whatever nature,
relating to the Company, its products and/or its services, including reports, files, memoranda, records, software, credit cards, door and file keys, computers, computer access codes, disks and instructional manuals and other physical or personal
property which the Executive received, prepared or helped prepare in connection with the Executive’s employment with the Company. The Executive further agrees that he will not keep any copies or excerpts of any of the above items, other than
personal items of continuing utility to the Executive. 
 10. Executive’s Understanding. The Executive acknowledges by signing this Agreement
that the Executive has read and understands this document, that the Executive has conferred with or had opportunity to confer with the Executive’s attorney regarding the terms and meaning of this Agreement, that the Executive has had sufficient
time to consider the terms provided for in this Agreement, that no representations or inducements have been made to the Executive except as set forth in this Agreement, and that the Executive has entered into this Agreement knowingly and
voluntarily. 
 11. Miscellaneous. 

(a) Entire Agreement. This Agreement represents the entire and only understanding between the parties on the subject matter hereof and
supersedes any other agreements or understandings between them on such subject matter. 
 (b) Binding Effect, Successors and Assigns.
This Agreement shall be binding upon and inure to the benefit of the heirs, executors, administrators, successors and assigns of the respective parties. Without the express written consent of the other party, neither the Company nor the Executive
may assign any duties or right or interest hereunder or right to receive any 

  
 - 5 - 

 
money hereunder and any such assignment shall be void; provided, however, that without the Executive‘s consent the Company may assign its rights and obligations hereunder in their entirety
to any successor to all or substantially all of its business, whether effected by merger or otherwise. 
 (c) Severability and
Amendment. In the event any provision of this Agreement shall be determined in any circumstances to be invalid or unenforceable, such determination shall not affect or impair any other provision of this Agreement or the enforcement of such
provision in other appropriate circumstances. This Agreement may be modified only by an instrument in writing executed by the parties hereto. 

(d) Interpretative Matters; Counterparts. The headings of sections of this Agreement are for convenience of reference only and shall
not affect its meaning or construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of strict construction will be applied against any party. This Agreement
may be executed in multiple counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. In making proof of this Agreement it shall not be necessary to produce or account for more
than one such counterpart. 
 (e) Governing Law and Conflicts. This Agreement is to be governed and construed according to the
internal substantive laws of the Commonwealth of Pennsylvania, without regard to the principles of the conflicts of laws thereof. 

  
 - 6 - 

 IN WITNESS WHEREOF, and intending to be legally bound, the parties have executed this Agreement
as of the date first written above. 
  

	
	UNION ELECTRIC STEEL CORPORATION
	
	 /s/ Rose Hoover

	Rose Hoover, Vice President
	
	EXECUTIVE
	
	 /s/ Robert G. Carothers

	Robert G. Carothers

  
 - 7 -EX-10.1

 Exhibit 10.1 

Execution Version 

VOTING AGREEMENT 
 This
VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), and the shareholders of IMS Health Holdings, Inc., a
Delaware corporation (“IMS Health”), listed on Schedule A hereto (each, a “Shareholder” and, collectively, the “Shareholders”). 

RECITALS 
 WHEREAS,
concurrently herewith, Quintiles and IMS Health are entering into an Agreement and Plan of Merger (the “Merger Agreement”; capitalized terms used but not defined in this Agreement shall have the meanings ascribed to them in the
Merger Agreement), pursuant to which (and upon the terms and subject to the conditions set forth therein) IMS Health will be merged with and into Quintiles, with Quintiles continuing as the surviving corporation in the merger on the terms and
subject to the conditions of the Merger Agreement (the “Merger”); 
 WHEREAS, each Shareholder is the record and/or
“beneficial owner” (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) of the number of common shares, par value $0.01 per share, of IMS Health (“Shares”) set forth opposite such
Shareholder’s name on Schedule A hereto (with respect to each Shareholder, the “Owned Shares”; the Owned Shares and any additional Shares or other voting securities of IMS Health of which such Shareholder acquires
record or beneficial ownership after the date hereof, including by purchase, as a result of a stock dividend, stock split, recapitalization, combination, reclassification, exchange or change of such shares, or upon exercise or conversion of any
securities, such Shareholder’s “Covered Shares”); 
 WHEREAS, as a condition and inducement to Quintiles’
willingness to enter into the Merger Agreement and to proceed with the transactions contemplated thereby, including the Merger, Quintiles and the Shareholders are entering into this Agreement; and 

WHEREAS, the Shareholders acknowledge that Quintiles is entering into the Merger Agreement in reliance on the representations, warranties,
covenants and other agreements of the Shareholders set forth in this Agreement and would not enter into the Merger Agreement if any Shareholder did not enter into this Agreement. 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, Quintiles and the Shareholders hereby agree as follows: 

1. Agreement to Vote. Prior to the Termination Date (as defined herein), each Shareholder irrevocably and unconditionally agrees that
it shall, at any meeting of the shareholders of IMS Health (whether annual or special and whether or not an adjourned or postponed meeting), however called, or in connection with any action proposed to be taken

 
by written consent of the shareholders of IMS Health (a) when a meeting is held, appear at such meeting or otherwise cause the Covered Shares to be counted as present thereat for the purpose
of establishing a quorum, and respond to each request by IMS Health for written consent, if any, and (b) vote (or consent), or cause to be voted at such meeting (or validly execute and return and cause such consent to be granted with respect
to), all Covered Shares (i) in favor of the adoption of the Merger Agreement and any other matter that is required to facilitate the Merger and/or the other transactions contemplated by the Merger Agreement, including the Governance Matters,
and (ii) against (A) any Acquisition Proposal with respect to IMS Health (an “IMS Health Acquisition Proposal”), (B) any other action, agreement or proposal that could reasonably be expected to impede, interfere with,
delay, postpone, frustrate, prevent, nullify or adversely affect the Merger or any of the transactions contemplated by the Merger Agreement or this Agreement or change in any manner the voting rights of any class of the capital stock of IMS Health,
(C) any change in the present capitalization or dividend policy of IMS Health or any amendment or other change to IMS Health’s certificate of incorporation or bylaws, except the Governance Matters or if approved by Quintiles, and
(D) any other change in IMS Health’s corporate structure or business. In the event that such Shareholder’s proxy has been granted to Quintiles pursuant to Section 2(a), such Shareholder shall have no obligations under this
Section 1 with respect to the meeting of the shareholders of IMS Health for which such proxy has been granted. Except as explicitly set forth in this Section 1, nothing in this Agreement shall limit the right of each Shareholder to vote
(including by proxy or written consent, if applicable) in favor of, against or abstain with respect to any matters presented to IMS Health’s shareholders. 

2. Grant of Irrevocable Proxy; Appointment of Proxy. 

(a) EACH SHAREHOLDER HEREBY GRANTS TO, AND APPOINTS, QUINTILES AS SUCH SHAREHOLDER’S IRREVOCABLE (UNTIL THE TERMINATION DATE) PROXY AND
ATTORNEY-IN-FACT (WITH FULL POWER OF SUBSTITUTION) TO VOTE THE COVERED SHARES AS INDICATED IN SECTION 1. EACH SHAREHOLDER INTENDS THIS PROXY TO BE IRREVOCABLE (UNTIL THE TERMINATION DATE) AND COUPLED WITH AN INTEREST AND WILL TAKE SUCH FURTHER
ACTION OR EXECUTE SUCH OTHER INSTRUMENTS AS MAY BE NECESSARY TO EFFECTUATE THE INTENT OF THIS PROXY AND HEREBY REVOKES ANY PROXY PREVIOUSLY GRANTED BY SUCH SHAREHOLDER WITH RESPECT TO THE COVERED SHARES (SUCH SHAREHOLDER REPRESENTING TO QUINTILES
THAT ANY SUCH PROXY IS NOT IRREVOCABLE). 
 (b) It is hereby agreed that Quintiles will use the proxy granted in Section 2(a) solely in
accordance with applicable Law and will only vote the Covered Shares subject to such proxy with respect to the matters and in the manner specified in Section 1. 

(c) The proxy granted in Section 2(a) shall automatically terminate, and any underlying appointment shall automatically be revoked and
rescinded and of no force and effect, upon the Termination Date, in each case without any further action by any party. 

  
 2 

 3. No Inconsistent Agreements. Each Shareholder hereby represents, covenants and agrees
that, except as contemplated by this Agreement, such Shareholder (a) has not, except for the Amended and Restated Shareholders’ Agreement, dated as of April 9, 2014, by and among IMS Health and the Sponsors (as defined therein) (the
“IMS Health SHA”), entered into, and shall not enter into at any time prior to the Termination Date, any voting agreement or voting trust with respect to any Covered Shares and (b) has not granted, and shall not grant at any
time prior to the Termination Date, a proxy or power of attorney with respect to any Covered Shares, in either case, which is inconsistent with such Shareholder’s obligations pursuant to this Agreement. 

4. Termination. This Agreement shall terminate upon the earliest of (a) the Effective Time, (b) the termination of the Merger
Agreement in accordance with its terms, (c) written notice of termination of this Agreement by Quintiles to the Shareholders (d) the entry into any amendment or modification of the Merger Agreement without the prior written consent of the
Shareholders or any waiver of any of IMS Health’s rights under the Merger Agreement, in each case, which (i) results in a change in the amount or form of the Merger Consideration, (ii) results in an extension of the Outside Date or
(iii) is materially adverse to any of the Shareholders and (e) the date on which the IMS Health Board effects an IMS Health Adverse Recommendation Change (such earliest date being referred to herein as the “Termination
Date”); provided that the provisions set forth in this Section 4, Section 7 and Sections 11 to 29 shall survive the termination of this Agreement; provided further that any liability incurred by any party hereto as a
result of a breach of a term or condition of this Agreement prior to such termination shall survive the termination of this Agreement. 
 5.
Representations and Warranties. 
 (a) Each Shareholder, as to itself (severally and not jointly), hereby represents and warrants to
Quintiles as follows: 
 (i) Such Shareholder is the record and/or beneficial owner of, and has good and valid title to, the Owned Shares,
free and clear of Liens other than as created by this Agreement. Such Shareholder has voting power, power of disposition, sole power to demand appraisal or dissenter rights, if any, and sole power to agree to all of the matters set forth in this
Agreement, in each case with respect to all of such Owned Shares, with no limitations, qualifications or restrictions on such rights, subject to applicable federal securities laws and the terms of this Agreement, except (x) as set forth below
in this Section 5(a)(i) with regard to the IMS Health SHA and (y) that each Shareholder may be deemed to share voting power and power of disposition over the Owned Shares with certain of its affiliates. As of the date hereof, other than
the Owned Shares, such Shareholder does not own beneficially or of record any (i) shares of capital stock or voting securities of IMS Health, (ii) securities of IMS Health convertible into or exchangeable for shares of capital stock or
voting securities of IMS Health or (iii) options or other rights to acquire from IMS Health any capital stock, voting securities or securities convertible into 

  
 3 

 
or exchangeable for capital stock or voting securities of IMS Health. Other than the IMS Health SHA and that certain Coordination Agreement, dated as of April 9, 2014, by and among the IMS
Health shareholders that are party thereto, the Owned Shares are not subject to any voting trust agreement or other Contract to which such Shareholder is a party restricting or otherwise relating to the voting or Transfer (as defined below) of the
Owned Shares. Such Shareholder has not appointed or granted any proxy or power of attorney that is still in effect with respect to any Owned Shares, except as contemplated by this Agreement. 

(ii) Such Shareholder is duly organized, validly existing and, to the extent applicable in good standing, under the laws of the jurisdiction
of its formation and has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder. The execution, delivery and performance of this Agreement by such Shareholder, the performance by such
Shareholder of its obligations hereunder and the consummation by such Shareholder of the transactions contemplated hereby have been duly and validly authorized by such Shareholder and no other actions or proceedings on the part of such Shareholder
are necessary to authorize the execution and delivery by such Shareholder of this Agreement, the performance by such Shareholder of its obligations hereunder or the consummation by such Shareholder of the transactions contemplated hereby. This
Agreement has been duly and validly executed and delivered by such Shareholder and, assuming due authorization, execution and delivery by Quintiles, constitutes a legal, valid and binding obligation of such Shareholder, enforceable against such
Shareholder in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general principles of equity
(regardless of whether considered in a proceeding in equity or at law). 
 (iii) Except for the applicable requirements of the Exchange
Act, (i) no filing with, and no permit, authorization, consent or approval of, any Governmental Entity is necessary on the part of such Shareholder for the execution, delivery and performance of this Agreement by such Shareholder or the
consummation by such Shareholder of the transactions contemplated hereby and (ii) neither the execution, delivery or performance of this Agreement by such Shareholder nor the consummation by such Shareholder of the transactions contemplated
hereby nor compliance by such Shareholder with any of the provisions hereof shall (A) conflict with or violate any provision of the organizational documents of such Shareholder, (B) result in any breach or violation of, or constitute a
default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a Lien on such property or asset
of such Shareholder pursuant to, any Contract to which such Shareholder is a party or by which such Shareholder or any property or asset of such Shareholder is bound or affected or (C) violate any order, writ, injunction, decree, statute, rule
or regulation applicable to such Shareholder or any of such Shareholder’s properties or assets, except, in the case of clause (B) or (C), for breaches, violations or defaults that would not, individually or in the aggregate, materially
impair the ability of such Shareholder to perform its obligations hereunder. 

  
 4 

 (iv) There is no action, suit, investigation, complaint or other proceeding pending against such
Shareholder or, to the knowledge of such Shareholder, any other Person or, to the knowledge of such Shareholder, threatened against such Shareholder or any other Person that restricts or prohibits (or, if successful, would restrict or prohibit) the
exercise by Quintiles of its rights under this Agreement or the performance by any party of its obligations under this Agreement. 
 (v) No
broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the transactions contemplated by the Merger Agreement or this Agreement based upon arrangements made by or on behalf of
such Shareholder. 
 (vi) Such Shareholder understands and acknowledges that Quintiles is entering into the Merger Agreement in reliance
upon such Shareholder’s execution and delivery of this Agreement and the representations and warranties of such Shareholder contained herein. 

(b) Quintiles hereby represents and warrants to each Shareholder as follows: 

(i) Quintiles is duly organized, validly existing and, to the extent applicable in good standing, under the laws of the jurisdiction of its
formation and has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder. The execution, delivery and performance of this Agreement by Quintiles, the performance by Quintiles of its
obligations hereunder and the consummation by Quintiles of the transactions contemplated hereby have been duly and validly authorized by Quintiles and no other actions or proceedings on the part of Quintiles are necessary to authorize the execution
and delivery by Quintiles of this Agreement, the performance by Quintiles of its obligations hereunder or the consummation by Quintiles of the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by
Quintiles and, assuming due authorization, execution and delivery by the Shareholders, constitutes a legal, valid and binding obligation of Quintiles, enforceable against Quintiles in accordance with its terms, except as enforcement may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general principles of equity (regardless of whether considered in a proceeding in equity or at law). 

(ii) Except for the applicable requirements of the Exchange Act, (i) no filing with, and no permit, authorization, consent or approval
of, any Governmental Entity is necessary on the part of Quintiles for the execution, delivery and performance of this Agreement by Quintiles or the consummation by Quintiles of the transactions contemplated hereby and (ii) neither the
execution, delivery or performance of this Agreement by Quintiles nor the consummation by Quintiles of the transactions contemplated hereby nor compliance by Quintiles with any of the provisions hereof shall (A) conflict with or violate, any
provision of the organizational documents of Quintiles, (B) result in any breach or violation of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights

  
 5 

 
of termination, amendment, acceleration or cancellation of, or result in the creation of a Lien on such property or asset of Quintiles pursuant to, any Contract to which Quintiles is a party or
by which Quintiles or any property or asset of Quintiles is bound or affected or (C) violate any order, writ, injunction, decree, statute, rule or regulation applicable to Quintiles or any of Quintiles’ properties or assets except, in the
case of clause (B) or (C), for breaches, violations or defaults that would not, individually or in the aggregate, materially impair the ability of Quintiles to perform its obligations hereunder. 

(iii) There is no action, suit, investigation, complaint or other proceeding pending against Quintiles or, to the knowledge of Quintiles, any
other Person or, to the knowledge of Quintiles, threatened against Quintiles or any other Person that restricts or prohibits (or, if successful, would restrict or prohibit) the exercise by any Shareholder of its rights under this Agreement or the
performance by any party of its obligations under this Agreement. 
 6. Certain Covenants of Shareholder. Each Shareholder, for
itself (severally and not jointly), hereby covenants and agrees as follows: 
 (a) Subject to Section 7, prior to the Termination Date,
such Shareholder shall not, and shall not authorize or permit any of its Subsidiaries or controlled affiliates, or authorized any of their respective directors, officers, employees, consultants, financial advisors, accountants, legal counsel,
investment bankers, and other agents, advisors and representatives, directly or indirectly, to: 
 (i) solicit, initiate, endorse,
encourage or facilitate the making by any Person (other than the other parties to the Merger Agreement) of any IMS Health Acquisition Proposal; 

(ii) other than to inform any Person of the existence of the provisions contained in this Section 6, enter into, continue or otherwise
participate in any discussions or negotiations regarding, or furnish to any Person any information or data with respect to, or otherwise cooperate in any way with, any IMS Health Acquisition Proposal; 

(iii) execute or enter into any Contract constituting or relating to any IMS Health Acquisition Proposal, or approve or recommend or propose
to approve or recommend any IMS Health Acquisition Proposal or any Contract constituting or relating to any IMS Health Acquisition Proposal (or authorize or resolve to agree to do any of the foregoing actions); or 

(iv) make, or in any manner participate in a “solicitation” (as such term is used in the rules of the Securities and Exchange
Commission (the “SEC”)) of proxies or powers of attorney or similar rights to vote, or seek to advise or influence any Person with respect to the voting of the Shares intending to facilitate any IMS Health Acquisition Proposal or
cause shareholders of IMS Health not to vote to approve the Merger or any other transaction contemplated by the Merger Agreement, 

  
 6 

 
provided that the provisions of this Section 6(a) shall only apply to a Shareholder’s or its Subsidiaries’ or controlled affiliates’ consultants, financial advisors,
accountants, legal counsel, investment bankers, and other agents, advisors and representatives (each, a “Third Party”) to the extent such Third Party is acting on behalf of, or was encouraged by, the Shareholder or its Subsidiaries
or controlled affiliates. 
 (b) Such Shareholder will immediately cease and cause to be terminated all existing discussions or negotiations
with any Person conducted heretofore with respect to any of the matters described in Section 6(a) above. 
 (c) Prior to the
Termination Date, and except as contemplated hereby, such Shareholder shall not, without the prior written consent of Quintiles, (i) tender any Covered Shares into any tender or exchange offer, (ii) sell (constructively or otherwise),
transfer, pledge, hypothecate, grant, encumber, assign or otherwise dispose of (other than to an affiliate of such Shareholder that agrees in writing to be bound by the terms hereof and that certain Shareholders Agreement, dated as of the date
hereof, by and among Quintiles and certain shareholders party thereto) (collectively, “Transfer”), or enter into any contract, option, agreement or other arrangement or understanding with respect to the Transfer of, any of the
Covered Shares or beneficial ownership or voting power thereof or therein (including by operation of law), (iii) grant any proxies or powers of attorney, deposit any Covered Shares into a voting trust or enter into a voting agreement with
respect to any Covered Shares or (iv) knowingly take any action that would make any representation or warranty of such Shareholder contained herein untrue or incorrect or have the effect of preventing or disabling such Shareholder from
performing its obligations under this Agreement. Any Transfer in violation of this provision shall be void. Such Shareholder further agrees to authorize and request IMS Health to notify IMS Health’s transfer agent that there is a stop transfer
order with respect to all of the Covered Shares and that this Agreement places limits on the voting of the Covered Shares; provided, however, that any such stop transfer order shall terminate upon the Termination Date. 

(d) Prior to the Termination Date, in the event that such Shareholder acquires record or beneficial ownership of, or the power to vote or
direct the voting of, any additional Shares or other voting interests with respect to IMS Health, such Shares or voting interests shall, without further action of the parties, be deemed Covered Shares and subject to the provisions of this Agreement,
and the number of Shares held by such Shareholder set forth on Schedule A hereto will be deemed amended accordingly and such Shares or voting interests shall automatically become subject to the terms of this Agreement. Such Shareholder shall
promptly notify IMS Health and Quintiles of any such event. 
 7. Shareholder Capacity. This Agreement is being entered into by each
Shareholder solely in its capacity as a shareholder of IMS Health, and nothing in this Agreement shall restrict or limit the ability of any Shareholder who is a director or officer of IMS Health, or any Person who is a director or officer of IMS
Health who may be affiliated or associated with, or nominated by, any Shareholder or any of its affiliates, from exercising his or her fiduciary duties as a director or officer of IMS Health or from otherwise taking any action or inaction in his or
her capacity as a director or officer of IMS 

  
 7 

 
Health to the extent specifically permitted by the Merger Agreement, or subject to his fiduciary duties to IMS Health, or as he may otherwise be required by Law, and no such exercise of fiduciary
duties or action or inaction taken in such capacity as a director or officer of IMS Health shall be deemed to constitute a breach of this Agreement. For the avoidance of doubt, nothing in this Section 7 is intended to limit the obligations of
IMS Health under the Merger Agreement. 
 8. Disclosure. Each Shareholder hereby authorizes IMS Health and Quintiles to publish and
disclose in any announcement or disclosure required by the SEC and in the Joint Proxy Statement/Prospectus such Shareholder’s identity and ownership of the Covered Shares and the nature of such Shareholder’s obligations under this
Agreement, provided that IMS Health and Quintiles shall give each Shareholder and its legal counsel a reasonable opportunity to review and comment on any such announcement or disclosure prior to its being made public. Except as may be required by
applicable Law, no press release or other public statements by any Shareholder regarding this Agreement, the transactions contemplated hereby, the Merger Agreement or the transactions thereby are permitted, other than press releases or other public
statements that are not inconsistent with previous press releases, public disclosures or public statements made jointly by IMS Health and Quintiles. 

9. Further Assurances. From time to time, at the request of Quintiles and without further consideration, each Shareholder shall take
such further action as may reasonably be deemed by Quintiles to be necessary or desirable to consummate and make effective the transactions contemplated by this Agreement. 

10. Non-Survival of Representations and Warranties. The representations and warranties of the Shareholders contained herein shall not
survive the closing of the transactions contemplated hereby and by the Merger Agreement. 
 11. Expenses. All costs and expenses
incurred in connection with this Agreement and the obligations hereunder shall be paid by the party incurring such costs and expenses, whether or not the transactions contemplated by the Merger Agreement are consummated. 

12. Amendment and Modification. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct
or otherwise, except by an instrument in writing specifically designated as an amendment hereto, signed on behalf of each party and otherwise as expressly set forth herein. 

13. Waiver. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall
any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or
power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder. Any agreement on the part of a party to any such waiver shall be valid only if set
forth in a written instrument executed and delivered by a duly authorized officer on behalf of such party. 

  
 8 

 14. Notices. All notices and other communications hereunder shall be in writing and shall
be deemed duly given (a) on the date of delivery if delivered personally, or if by facsimile or e-mail, upon written confirmation of receipt by facsimile, e-mail or otherwise, (b) on the first Business Day following the date of dispatch if
delivered utilizing a next-day service by a recognized next-day courier or (c) on the earlier of confirmed receipt or the fifth Business Day following the date of mailing if delivered by registered or certified mail, return receipt requested,
postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice: 

(i) If to a Shareholder, to the address set forth opposite such Shareholder’s name on Schedule A hereto. 

(ii) If to Quintiles: 

Quintiles Transnational Holdings Inc. 

4820 Emperor Blvd. 
 Durham,
North Carolina 27703 
 Attention: James H. Ehrlinger III 

Facsimile: (919) 948-4038 

E-mail: James.Erlinger@quintiles.com 

with a copy (which shall not constitute notice) to: 

Bryan Cave LLP 
 One
Metropolitan Square 
 211 North Broadway, Suite 3600 

St. Louis, Missouri 63102 

Attention:        William F. Seabaugh 

Attention:        James M. Attonito 

Facsimile: (314) 259-2020 

E-mail: wfseabaugh@bryancave.com 

E-mail: james.attonito@bryancave.com 

15. Entire Agreement. This Agreement constitutes the entire agreement, and supersedes all prior written agreements, arrangements,
communications and understandings and all prior and contemporaneous oral agreements, arrangements, communications and understandings among the parties with respect to the subject matter hereof. 

16. No Third-Party Beneficiaries. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person other
than the parties and their respective successors and permitted assigns any legal or equitable right, benefit or remedy of any nature under or by reason of this Agreement. 

  
 9 

 17. Governing Law. This Agreement and all disputes or controversies arising out of or
relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to the laws of any other jurisdiction that might be applied because
of the conflicts of laws principles of the State of Delaware. 
 18. Submission to Jurisdiction. Each of the parties hereto
irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by any party hereto or its Affiliates against any other party hereto or its Affiliates shall be brought and determined in the Court of
Chancery of the State of Delaware in and for New Castle County, Delaware, provided that if jurisdiction is not then available in the Court of Chancery of the State of Delaware in and for New Castle County, Delaware, then any such legal action or
proceeding may be brought in any federal court located in the State of Delaware or any other Delaware state court. Each of the parties hereto hereby irrevocably submits to the jurisdiction of the aforesaid courts for itself and with respect to its
property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties hereto agrees not to commence any action, suit or
proceeding relating thereto except in the courts described above in Delaware, other than actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the
parties hereto further agrees that notice as provided herein shall constitute sufficient service of process and the parties hereto further waive any argument that such service is insufficient. Each of the parties hereto hereby irrevocably and
unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement, (a) any claim that it is not personally subject to the
jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of
notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the
venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts. 

19. Assignment; Successors. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned
or delegated, in whole or in part, by operation of law or otherwise, by any party without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void. Subject to the preceding
sentence, this Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors and assigns. 

20. Enforcement. The parties agree that irreparable damage would occur in the event that the parties hereto do not perform the
provisions of this Agreement in accordance with its terms or otherwise breach such provisions. Accordingly, prior to any termination of this Agreement pursuant to Section 4, the parties acknowledge and agree that each party shall be entitled to
an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in 

  
 10 

 
the Court of Chancery of the State of Delaware in and for New Castle County, Delaware, provided that if jurisdiction is not then available in the Court of Chancery of the State of Delaware in and
for New Castle County, Delaware, then in any federal court located in the State of Delaware or any other Delaware state court, this being in addition to any other remedy to which such party is entitled at law or in equity. Each of the parties hereby
further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security as a prerequisite to obtaining equitable relief. 

21. Severability. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner
as to be effective and valid under applicable Law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable Law or rule in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provision or portion of any provision had never been contained herein. 
 22. Waiver of Jury Trial. EACH OF THE PARTIES
TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

23. Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same
instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party. 

24. Facsimile or .pdf Signature. This Agreement may be executed by facsimile or .pdf signature and a facsimile or .pdf signature shall
constitute an original for all purposes. 
 25. Confidentiality. Each Shareholder agrees (a) to hold any non-public information
regarding this Agreement and the Merger in strict confidence and (b) except as required by Law or legal process not to divulge any such non-public information to any third Person; provided, however, that each Shareholder may disclose non-public
information to its financial advisors, legal counsel and other representatives, in each case, so long as such Person is bound by a customary confidentiality agreement or otherwise subject to comparable confidentiality obligations. 

26. Interpretation. When a reference is made in this Agreement to a Section or Schedule such reference shall be to a Section or
Schedule of this Agreement unless otherwise indicated. The headings contained in this Agreement or in any Schedule are for convenience of reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. All
words used in this Agreement will be construed to be of such gender or number as the circumstances require. Any capitalized terms used in any Schedule but not otherwise defined therein shall have the meaning as defined in this

  
 11 

 
Agreement. All Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth herein. The word “including” and words of
similar import when used in this Agreement will mean “including, without limitation,” unless otherwise specified. The words “hereof,” “herein” and “hereunder” and words of similar import when used in this
Agreement shall refer to the Agreement as a whole and not to any particular provision in this Agreement. The term “or” is not exclusive. The word “will” shall be construed to have the same meaning and effect as the word
“shall.” References to days mean calendar days unless otherwise specified. 
 27. No Presumption Against Drafting Party.
Each of the parties to this Agreement acknowledges that each party to this Agreement has been represented by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law or any legal
decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party has no application and is expressly waived. 

28. Obligations of Shareholders. Notwithstanding anything to the contrary in this Agreement, the representations, warranties, covenants
and agreements of each Shareholder are several and not joint and several, and in no event shall any Shareholder have any obligation or liability for any of the representations, warranties and covenants of any other Shareholder. 

29. No Ownership Interest. Except as specifically provided herein, (a) all rights, ownership and economic benefits of and relating
to a Shareholder’s Covered Shares shall remain vested in and belong to such Shareholder and (b) Quintiles shall have no authority to exercise any power or authority to direct or control the voting or disposition of any Shares or direct
such Shareholder in the performance of its duties or responsibilities as a shareholder of IMS Health other than the right to vote the Shareholder’s Covered Shares as proxy upon the terms and subject to the conditions of this Agreement. Nothing
in this Agreement shall be interpreted as creating or forming a “group” with any other Person, including Quintiles, for purposes of Rule 13d-5(b)(1) of the Exchange Act or any other similar provision of applicable law. 

30. Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall apply to (i) restrict any actions taken
by (x) any third-party investment manager managing any investments of any Shareholder or any of its affiliates who have discretionary authority with respect to such investments, or (y) any portfolio company, investment fund or pooled
investment vehicle in which any Shareholder or any of its affiliates may directly or indirectly invest or (ii) any Shares acquired by any such investment manager exercising discretionary authority or any such portfolio company, investment fund
or pooled investment vehicle. 
 [The remainder of this page is intentionally left blank.] 

  
 12 

 IN WITNESS WHEREOF, the parties below have caused to be executed or executed this Agreement as of
the date first written above. 
  

			
	QUINTILES TRANSNATIONAL HOLDINGS INC.
		
	By:	 	  

	Name:	 	
	Title:	 	
		
	[●]	 	
	By:	 	[●]
		
	By:	 	  

	Name:	 	
	Title:	 	
		
	[●]	 	
	By:	 	[●]
		
	By:	 	  

	Name:	 	
	Title:	 	

 SCHEDULE A 
  

							
	 Shareholder
	  	 Address
	  	Owned Shares	 
	TPG Partners V, L.P., a Delaware limited partnership	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	46,237,965	  
			
	TPG Partners VI, L.P., a Delaware limited partnership	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	46,273,539	  

 SCHEDULE A 
  

							
	 Shareholder
	  	 Address
	  	Owned Shares	 
	TPG FOF V-A, L.P., a Delaware limited partnership	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	120,959	  
			
	TPG FOF V-B, L.P., a Delaware limited partnership	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	97,538	 

 SCHEDULE A 
  

							
	 Shareholder
	  	 Address
	  	Owned Shares	 
	TPG FOF VI SPV, L.P., a Delaware limited partnership	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	182,921	  
			
	TPG Biotechnology Partners III, L.P., a Delaware limited partnership	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	1,909,170	  

 SCHEDULE A 
  

							
	 Shareholder
	  	 Address
	  	Owned Shares	 
	TPG Iceberg Co-Invest LLC, a Delaware limited liability company	  	 301 Commerce Street, Suite 3300
 Fort Worth,
Texas 76102
 Attention: General Counsel
 Telephone: (817)
871-4000
 Fax: (817) 871-4001
 Email: legaldept@tpg.com

 
 with a copy (which shall not constitute notice) to:

 
 Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza
 New York, NY 10006

Attention: Paul J. Shim, Esq.
 Telephone: (212) 225-2000

Fax: (212) 225-3999
	  	 	15,909,748	  
		  		  	  
	  
	 
	Total	  	 	110,731,840

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]